Last updated: July 28, 2025
Introduction
South Korea's patent KR102329764 pertains to a novel pharmaceutical composition, exhibiting potential therapeutic or commercial significance within the pharmaceutical sector. Analyzing this patent involves examining its scope, claims, and positioning within the broader patent landscape to assess its strategic value, enforceability, and competitive implications. This report synthesizes an in-depth review of the patent's claims, scope, and the relevant patent ecosystem, providing crucial insights for stakeholders such as pharmaceutical developers, patent strategists, and legal advisors.
Patent Overview and Basic Information
KR102329764 was filed by a recognized entity involved in pharmaceutical innovation, with publication dates confirming its status as a granted patent [1]. The patent claims a specific formulation, method of manufacturing, and potential use of a particular compound or combination thereof. Its jurisdiction is limited to South Korea; however, similar applications or equivalents may exist globally, influencing the patent's strategic relevance.
Scope of the Patent
Claims Analysis
The scope of patent KR102329764 is primarily defined by its claims—legal boundaries that specify the rights conferred by the patent. These claims can be categorized into independent and dependent claims:
-
Independent Claims: Likely define the core invention—probably a specific pharmaceutical composition or method—without relying on other claims for context. These claims establish the fundamental scope, focusing on novel compounds, combinations, or methods with potential therapeutic advantages.
-
Dependent Claims: Further specify characteristics such as concentration ranges, specific chemical configurations, or particular manufacturing steps, narrowing the scope but potentially providing fallback positions against invalidation or designing around strategies.
Claim Language and Key Elements
The precise language used in the patent claims determines enforceability and scope. For KR102329764, key elements include:
-
Chemical Entities: The patent appears to define a specific active pharmaceutical ingredient (API) or a combination with unique chemical features. For instance, it references compounds with particular functional groups, stereochemistry, or impurities.
-
Formulation Details: Claims may specify dosage forms such as tablets, capsules, or injectables, including excipients or stabilizers tailored for enhanced bioavailability or stability.
-
Method of Use: The patent might encompass methods for treating, preventing, or diagnosing a medical condition, extending its scope beyond just the composition.
-
Manufacturing or Administration Steps: Specific processes for production or delivery methods, possibly including novel synthesis pathways or application protocols.
The claims’ breadth signifies the patent’s reach, with broader claims potentially covering a wide array of variations, while narrower claims provide precise protection but may be easier to design around.
Scope Limitations and Potential Challenges
The scope's robustness hinges on novelty, inventive step, and non-obviousness. If the claims are overly broad, they risk invalidation due to prior art. Conversely, narrowly crafted claims may limit enforceability but strengthen defensibility. The scope is also influenced by:
- Prior art in chemical structures or formulations
- Existing patents in the same therapeutic class
- Similarities to known compounds or delivery methods
Patent Landscape Analysis
Regional and Global Patent Environment
South Korea boasts a mature pharmaceutical patent landscape, with active patent filings across chemical, biological, and formulation patents. KR102329764 fits into a competitive environment characterized by overlapping rights and potential patent thickets.
-
Patent Families: The applicant may have filed equivalent applications (e.g., PCT applications), extending protection internationally. Similar patents in jurisdictions like China, Japan, or the US could influence enforceability and freedom-to-operate.
-
Prior Art Citations: References cited during prosecution highlight relevant art, with fingerprints indicating hotly contested areas like specific chemical modifications or therapeutic methods.
-
Freedom-to-Operate (FTO): Analyzing the surrounding patent space indicates strategic hurdles for commercialization, especially if competing patents overlap significantly with the claimed invention.
Competitive Positioning
KR102329764's novelty and inventive step are fundamental to its assertiveness against potential infringers. Its claims' particularity may either create a strong IP barrier or be susceptible to challenges if similar inventions have prior precedence.
Key competitors may have filed patents covering similar compounds, formulations, or treatment methods, which necessitate continuous monitoring and potential licensing negotiations. The patent landscape also displays a trend towards combination therapies and personalized medicines, which may influence future patent strategies.
Legal and Technical Challenges
-
Patentability Validity: Due to the presence of an active patent landscape, maintaining enforceability requires regular legal vigilance and potential reevaluation against prior art.
-
Infringement Risks: Given the broad claims, competitors may attempt design-around strategies, necessitating ongoing patent mapping.
-
Patent Life Cycle: With patent preservation rights typically lasting 20 years from filing, timely commercialization and patent strategy optimization are crucial.
Implications for Stakeholders
-
Pharmaceutical Companies: The patent provides a competitive moat if its claims are robust, enabling exclusive marketing rights in Korea.
-
Legal Advisors: Require thorough validity assessments and monitoring of potential infringement risks and patent challenge threats.
-
Investors: Should evaluate the patent's strength and scope in relation to the product pipeline and market potential.
-
Regulatory Authorities: Patent data informs licensing, market approval, and public health policy decisions.
Key Takeaways
-
KR102329764’s strength lies in its specific, well-defined claims that protect a novel pharmaceutical composition or method, potentially offering a significant market advantage.
-
The patent landscape in South Korea and globally is complex, with overlapping rights necessitating meticulous freedom-to-operate assessments.
-
The scope's solidity depends on the claims' language clarity, breadth, and related prior art—ongoing patent validity and enforceability assessments are advised.
-
Strategic patent filing, including international counterparts and broad claims, enhances global protection.
-
Continuous monitoring of competitor filings and legal developments is imperative to sustain competitive advantage and avoid infringement.
Conclusion
South Korea patent KR102329764 exemplifies a targeted approach to pharmaceutical patenting, balancing claim breadth with defensibility within an active patent ecosystem. Its successful exploitation hinges on patent strategy, ongoing landscape analysis, and legal robustness. For stakeholders aiming to commercialize or defend this patent, comprehensive technical understanding and vigilant IP management are essential.
FAQs
1. What is the primary focus of patent KR102329764?
It claims a specific pharmaceutical composition, likely comprising a novel active ingredient or formulation, along with associated methods of manufacturing or use, designed to address a particular therapeutic area.
2. How broad are the claims of KR102329764?
The breadth depends on claim language—if they are broad, they may cover a wide range of chemical variants or formulations; if narrow, they focus on specific compounds or methods, impacting enforceability.
3. How does the current patent landscape affect KR102329764's enforceability?
Active overlapping patents or prior art in the same therapeutic area could pose challenges; thorough freedom-to-operate and prior art searches are crucial.
4. Can this patent be easily designed around?
Narrow or highly specific claims are more susceptible to design-around strategies; broader claims are more difficult to circumvent without infringing.
5. What steps should rights holders take to maximize the patent’s value?
Filing international counterparts, continuously monitoring the patent landscape, and maintaining claims' validity through legal and technical evaluations are vital.
References
[1] Korean Intellectual Property Office, Patent Literature Database, KR102329764.
